Quick Takeaways
- Kaos Capital Ltd filed SCHEDULE 13D/A for PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM).
- Disclosed ownership: 4.9%.
- Date of event: 08 Jan 2026.
Kaos Capital Ltd - 08 Jan 2026 SCHEDULE 13D/A Report for PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM)
- Filing Manager
- Kaos Capital Ltd
- Reporting Manager
- KAOS Capital Ltd.
- Symbol
- PBM
- Shares outstanding
- 6,392,587 shares
- Disclosed Ownership
- 313,876 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13D/A
- Filing time
- 13 Jan 2026, 18:17:19 UTC
- Date of event
- 08 Jan 2026
- Previous filing
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Kaos Capital Ltd disclosed 4.9% ownership in PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM) on 08 Jan 2026."
What Changed
- Previous schedule filing date: 10 Dec 2025.
- Current filing was accepted on 13 Jan 2026, 18:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KAOS Capital Ltd. | 4.9% | 313,876 | 0 | 313,876 | /s/ Adam Arviv | Adam Arviv / Chief Executive Officer | 0002100448 |
| Adam Arviv | 4.9% | 313,876 | 0 | 313,876 | /s/ Adam Arviv | Adam Arviv, Individually | 0002100451 |